A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people

Timothy Kwok(Shatin Hospital), J. Lee(Chinese University of Hong Kong), Chun Bon Law(Hospital Authority), P.C. Pan(United Christian Hospital), Cho Yiu Yung(United Christian Hospital), Kai Chow Choi(Chinese University of Hong Kong), Linda Lam(Chinese University of Hong Kong)

Clinical Nutrition

January 9, 2011

10.1016/j.clnu.2010.12.004

Cited by 81

Abstract

Related Papers

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

Carol J. Boushey|JAMA|1995|3.6k

Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease

Sudha Seshadri, Alexa Beiser, Jacob Selhub et al.|New England Journal of Medicine|2002|3.2k

Cornell scale for depression in dementia

George S. Alexopoulos, Robert C. Abrams, Robert C. Young et al.|Biological Psychiatry|1988|2.7k

Neurotoxicity associated with dual actions of homocysteine at the <i>N</i> -methyl- <scp>d</scp> -aspartate receptor

Stuart A. Lipton, Won-Ki Kim, Yun‐Beom Choi et al.|Proceedings of the National Academy of Sciences|1997|850

Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies

David G. Savage, John Lindenbaum, Sally P. Stabler et al.|The American Journal of Medicine|1994|713